Cargando…

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

Detalles Bibliográficos
Autores principales: Schmitz, M, Temme, A, Senner, V, Ebner, R, Schwind, S, Stevanovic, S, Wehner, R, Schackert, G, Schackert, H K, Fussel, M, Bachmann, M, Rieber, E P, Weigle, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359969/
http://dx.doi.org/10.1038/sj.bjc.6603802
_version_ 1782152931697491968
author Schmitz, M
Temme, A
Senner, V
Ebner, R
Schwind, S
Stevanovic, S
Wehner, R
Schackert, G
Schackert, H K
Fussel, M
Bachmann, M
Rieber, E P
Weigle, B
author_facet Schmitz, M
Temme, A
Senner, V
Ebner, R
Schwind, S
Stevanovic, S
Wehner, R
Schackert, G
Schackert, H K
Fussel, M
Bachmann, M
Rieber, E P
Weigle, B
author_sort Schmitz, M
collection PubMed
description
format Text
id pubmed-2359969
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23599692009-09-10 Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy Schmitz, M Temme, A Senner, V Ebner, R Schwind, S Stevanovic, S Wehner, R Schackert, G Schackert, H K Fussel, M Bachmann, M Rieber, E P Weigle, B Br J Cancer Corrigendum Nature Publishing Group 2007-06-18 2007-06-12 /pmc/articles/PMC2359969/ http://dx.doi.org/10.1038/sj.bjc.6603802 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Corrigendum
Schmitz, M
Temme, A
Senner, V
Ebner, R
Schwind, S
Stevanovic, S
Wehner, R
Schackert, G
Schackert, H K
Fussel, M
Bachmann, M
Rieber, E P
Weigle, B
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title_full Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title_fullStr Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title_full_unstemmed Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title_short Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
title_sort identification of sox2 as a novel glioma-associated antigen and potential target for t cell-based immunotherapy
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359969/
http://dx.doi.org/10.1038/sj.bjc.6603802
work_keys_str_mv AT schmitzm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT temmea identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT sennerv identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT ebnerr identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT schwinds identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT stevanovics identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT wehnerr identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT schackertg identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT schackerthk identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT fusselm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT bachmannm identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT rieberep identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy
AT weigleb identificationofsox2asanovelgliomaassociatedantigenandpotentialtargetfortcellbasedimmunotherapy